Inventor
ERIKSSON ULF
SE57 patents
⚠️ This page may combine multiple inventors who share the name “ERIKSSON ULF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUDWIG INST CANCER RES
20 patentsUS5840693ANov 24, 1998
Vascular endothelial growth factor-B
LUDWIG INST CANCER RES156 citations98
US5607918AMar 4, 1997
Vascular endothelial growth factor-B and DNA coding therefor
LUDWIG INST CANCER RES239 citations98
US6331301B1Dec 18, 2001
Antibodies specific for vascular endothelial growth factor-B
LUDWIG INST CANCER RES58 citations95
US5928939AJul 27, 1999
Vascular endothelial growth factor-b and dna coding therefor
LUDWIG INST CANCER RES65 citations95
US6706687B1Mar 16, 2004
Platelet-derived growth factor D
LUDWIG INST CANCER RES41 citations89
US9487579B2Nov 8, 2016
Methods and compositions for modulation of blood-neural barrier
LUDWIG INST CANCER RES3 citations80
US7709450B2May 4, 2010
Stimulation of vascularization with VEGF-B-186
LUDWIG INST CANCER RES6 citations72
US5731195AMar 24, 1998
Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with p63, a portion of a retinol binding protein receptor
LUDWIG INST CANCER RES5 citations72
US5573939ANov 12, 1996
DNA encoding mammalian retinol binding protein receptor, and corresponding vectors and transformed cells
LUDWIG INST CANCER RES13 citations69
US6262337B1Jul 17, 2001
Transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B DNA) and uses thereof
LUDWIG INST CANCER RES13 citations67
US6793918B2Sep 21, 2004
In vivo stimulation of angiogenic activity
LUDWIG INST CANCER RES12 citations66
US9078877B2Jul 14, 2015
Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases
LUDWIG INST CANCER RES1 citations63
US8383112B2Feb 26, 2013
Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases
LUDWIG INST CANCER RES1 citations63
US7341996B2Mar 11, 2008
Processed vascular endothelial growth factor-B polypeptides
LUDWIG INST CANCER RES3 citations62
US7034200B2Apr 25, 2006
Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof
LUDWIG INST CANCER RES3 citations60
US6399344B1Jun 4, 2002
Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding receptors
LUDWIG INST CANCER RES3 citations58
US6280997B1Aug 28, 2001
Isolated nucleic acid molecule which codes for a 32 KDA protein having 11-CIS retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor
LUDWIG INST CANCER RES4 citations58
US7476654B2Jan 13, 2009
Method for modulating, regulating and/or stabilizing angiogenesis
LUDWIG INST CANCER RES0 citations51
US6670125B2Dec 30, 2003
Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents
LUDWIG INST CANCER RES1 citations49
US5972646AOct 26, 1999
Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor
LUDWIG INST CANCER RES0 citations48
CSL LTD
6 patentsUS10961304B2Mar 30, 2021
Method of reducing the effect of a stroke comprising administering an inhibitor of vascular endothelial growth factor B (VEGF-B)
CSL LTD2 citations68
US9803008B2Oct 31, 2017
Method of treating diabetic nephropathy by administering antibodies to vascular endothelial growth factor B (VEGF-B)
CSL LTD2 citations68
US10336821B2Jul 2, 2019
Method of treating stroke by administering a compound that inhibits VEGF-B signaling in combination with a thrombolytic agent
CSL LTD1 citations58
US11261243B2Mar 1, 2022
Methods of treating diabetic nephropathy by administering an anti-vegf-b (vascular endothelial growth factor-b) antibody
CSL LTD0 citations57
US10543270B2Jan 28, 2020
Methods of treating wounds in a diabetic subject
CSL LTD0 citations47
US10407498B2Sep 10, 2019
Method of treating diabetic nephropathy in a subject suffering from type 2 diabetes by administering an antibody which inhibits VEGF-B signaling
CSL LTD0 citations47
ERIKSSON ULF
4 patentsUS8765671B2Jul 1, 2014
Methods and compositions for modulation of blood-neural barrier
ERIKSSON ULF3 citations69
US8147828B2Apr 3, 2012
Methods and compositions for modulation of blood-neural barrier
ERIKSSON ULF3 citations69
US8114399B2Feb 14, 2012
Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases
ERIKSSON ULF1 citations62
US8197348B2Jun 12, 2012
Telescopic shaft
ERIKSSON ULF5 citations60
LICENTIA LTD
3 patentsUS7105481B2Sep 12, 2006
Method for stimulating connective tissue growth or wound healing
LICENTIA LTD16 citations91
US6515105B1Feb 4, 2003
Neuropilin/growth factor complexes and uses thereof
LICENTIA LTD15 citations90
US7148037B2Dec 12, 2006
Platelet-derived growth factor D, DNA coding therefor, and uses thereof
LICENTIA LTD4 citations60
EDMESTON AB
2 patentsPARACRINE THERAPEUTICS AB
2 patentsLUDWIG INST FOR CANCER RES LTD
2 patentsMORA OF SWEDEN AB
1 patentERICSSON TELEFON AB L M
1 patentSANDVIK AB
1 patentVALMET OY
1 patentAFFARSVERKET FFV
1 patentFUJI AUTOTECH AB
1 patentVEGENICS PTY LTD
1 patentEIE MASKIN AB
1 patentUNIV HELSINKI LICENSING
1 patentANDERSSON BJOERN
1 patentHAMRA INVEST AB
1 patentShowing the top 50 of 57 patents by PatentIndex Score.